CAS: 7207-92-3; Nandrolone 17-Propionate

该化合物是一种代谢类固醇,产自睾丸酮,其特征为19°C结构,在19度位置没有碳原子,这种改变会增加其代谢特性,同时减少和诱因效应;通常用于兽医药物,以促进肌肉生长和牲畜食欲;氨化酮的半衰期相对较短,需要比其他硝化酮更加频繁地使用.该物质通常通过肌肉内注射来施用,并有利于其促进精质肌肉质量和改善运动员恢复时间的能力.然而,该物质的使用与潜在副作用有关,包括荷尔蒙失衡,心血管问题和肝毒性,特别是在滥用的情况下.由于其性能增强效应,在有竞争力的体育运动中禁用了硝化酮丙酮,因此,与所有代谢类甲醇类固醇一样,至关重要的是在医疗监督下使用该物质来减少风险并确保安全使用.

结构式图片

欧盟法规

ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

CAS号434-22-0 诺龙 | CAS号123-62-6 丙酸酐

合成工艺路线路线简述

    📜诺龙,丙酸酐 反应生成 丙酸诺龙
    参考文献:19-Nortestosterone Acylates And 3-Enol Acylates Thereof
    标题:19-Nortestosterone Acylates And 3-Enol Acylates Thereof

    海关参考信息

    专利信息


    专利号:CN-109678718-A
    优先权日:2019-01-16
    标 题 :Method for catalyzing synthesis of phenylpropionate derivatives by ionic liquid

    专利号:US-2025281509-A1
    优先权日:2021-04-26
    标 题 :Sequential hormone therapy to improve survival and enhance response to immune therapy in men with prostate cancer
    发明人:DENMEADE SAMUEL R; ISAACS JOHN T; ANTONARAKIS EMMANUEL S; KACHHAP SUSHANT; MARKOWSKI MARK CHRISTOPHER
    权利人:UNIV JOHNS HOPKINS
    摘要:Disclosed are methods for treating men with castrate resistant prostate cancer with a sufficient dose of testosterone to achieve supraphysiologic serum levels of testosterone in sequence with androgen ablative treatment or androgen synthesis inhibitors for one or more cycles until evidence of radiographic progression, at which point the subject will receive immune checkpoint blockade therapy.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
    参考文献:10.1016/j.chroma.2008.02.100
    摘要:Hadef Y, Kaloustian J, Portugal H, Nicolay A. Multivariate optimization of a derivatisation procedure for the simultaneous determination of nine anabolic steroids by gas chromatography coupled with mass spectrometry. J Chromatogr A. 2008 May 09;1190(1-2):278–85. doi: 10.1016/j.chroma.2008.02.100.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知